Introduction
Dystonia is a syndrome characterized primarily by excessive muscle contractions giving rise to abnormal posture and involuntary twisting movements [1] . Dystonia can be classified in a number of ways, according to the age at onset, distribution, presence of additional signs and aetiology [1] . The current classification relies on two axes: the first defines the clinical features and phenomenology of dystonia in any given patient, whereas the second addresses aetiological factors [1] . In most patients, however, definitive aetiological conclusions cannot be reached and the dystonia syndrome is hence referred to as idiopathic. Despite dystonia being a widely heterogeneous group of disorders, certain pathophysiological mechanisms have been consistently identified across different dystonia forms [2, 3] , at least for those considered idiopathic.
Three main abnormalities, which might be influencing each other, have been construed to represent the pathophysiological substrate of dystonia: loss of inhibition at different levels of the central nervous system, maladaptive (excessive) plasticity, and altered sensorimotor integration (for a review see [4] ). These pathophysiological mechanisms might explain some clinical phenomena frequently observed in dystonia such as the motor overflow and the presence of sensory symptoms. Such abnormalities have been demonstrated to occur at various levels of the central nervous system and dystonia is currently thought to be a network disorder involving the sensorimotor cortices, the basal ganglia and, possibly, the cerebellum [5] .
The current mainstream symptomatic therapy for dystonia is represented by chemodenervation by means of botulinum toxin (BoNT) injections [2] . However, whilst success rates in patients with cervical dystonia (CD) or blepharospasm are reasonably high, in patients with focal hand dystonia (FHD) outcomes are more often disappointing, also due to frequent adverse effects. Moreover, BoNT might not be sufficient when dystonia is distributed over several body regions, as in many children with generalized dystonia. The role of deep brain stimulation (DBS) in dystonia is fairly accepted for some dystonic conditions (i.e. DYT1, DYT6, DYT11, tardive dystonia) and is emerging for others, but not all patients are suitable candidates [6] . Therefore, alternative therapeutic approaches are clearly needed.
The putative pathophysiological mechanisms of dystonia have been exploited for the development of noninvasive brain stimulation (NIBS) techniques. These would be able to induce plastic changes in one or more nodes of the altered network and possibly reverse the aforementioned abnormalities [7] . The concept of neuromodulation holds onto the hope of translating such NIBS techniques into novel therapeutic strategies for dystonia [7] . Two other review articles [8, 9] have been previously produced about the therapeutic use of NIBS in dystonia, but both focused on patients with FHD only. Therefore, after giving the basic principles of NIBS, all articles using NIBS techniques for therapeutic purposes in any form of dystonia, including the works performed in children, are reviewed here. The focus is only on NIBS techniques (described in detail in the next section), hence not covering the applications of DBS for dystonia. Interested readers are therefore referred elsewhere [6, 10] .
Principles of non-invasive brain stimulation
Two main techniques are available for human NIBS: transcranial magnetic stimulation (TMS) and transcranial current stimulation (tCS). These neuromodulatory techniques are applied non-invasively over the scalp ( Fig. 1) and hence avoid the possible complications associated with DBS surgery and the side effects of systemic medications [7] [8] [9] 11, 12] . Theoretically, both can be applied over selected cortical regions to modulate the specific cortical-subcortical network that is supposedly linked with a given subset of symptoms. However, there is an established tendency of spread from the target brain area to neighbouring areas, which might undermine the topographic selectivity of these techniques. Moreover, both repetitive TMS (rTMS) and transcranial direct current stimulation (tDCS) might be uncomfortable for patients and further can produce side effects, including the possibility of inducing seizures, which made some authors argue that the term non-invasive would be inappropriate [13] . Perhaps the term minimally invasive might be more appropriate.
Beyond these two techniques, there is evidence that (peripheral) transcutaneous electrical nerve stimulation (TENS) can modulate motor cortex excitability [14] and it is therefore discussed here, despite not being classically considered an NIBS technique.
Repetitive TMS
Repetitive TMS refers to the application of trains of repeated magnetic pulses delivered to the scalp. Passing a brief current through an insulated coil placed on the scalp surface generates a magnetic field perpendicular to the coil that, in turn, induces a weak current within the underlying cerebral cortex. Commonly used coils have a figure-of-eight shape able to stimulate brain cortical areas with a functional spatial resolution of 0.5-1 cm [15] . Using TMS, neuromodulatory effects can be elicited in a number of ways depending mostly on the frequency and/or pattern of stimulation: low (<1 Hz) or high (>5 Hz) frequency rTMS decreases or increases, respectively, cortical excitability. The exact mechanisms by which rTMS modulates the cortical excitability beyond the duration of the stimulation protocol are not clear. It is supposed that these are explained by long-term potentiation (LTP) and long-term depression (LTD) changes at synaptic level [16] . Whilst these changes during the stimulation might be exerted by a direct influence on N-methyl-Daspartate-dependent plasticity, late-LTP and late-LTD changes are arguably driven by gene expression regulation and protein synthesis [16] .
An alternative method of rTMS is theta burst stimulation (TBS), consisting of short, repeated bursts of TMS pulses at high frequency. In this case, the neuromodulatory effect relies on the pattern of stimulation with continuous TBS (cTBS) having inhibitory effects and intermittent TBS facilitatory effects. In fact, a single train of TBS induces a mixture of suppressive and facilitatory effects, with facilitation building up faster and suppression being more powerful in the long term [17] . Since it is assumed that both mechanisms saturate at some level, the results might be explained by the duration of the stimulation (i.e. as long as inhibition builds up in the long run) [17] . Accordingly, a short, intermittent protocol such as intermittent TBS would favour rapid build-up of facilitation [17] . In contrast, a longer lasting continuous protocol such as cTBS would initially produce facilitation, but this would saturate and inhibitory effects (which build up more slowly but saturate at a higher level) would eventually dominate [17] . This argument is speculative, however, and the exact mechanisms whereby TBS induces plastic changes are not entirely clear, the effects also depending on the intensity of stimulation [18] [19] [20] .
It should be noted, however, that there might be a significant amount of inter-individual variability in response to such protocols. In fact, some subjects show facilitation after 1 Hz rTMS and others show excitability suppression after 10 Hz rTMS [21] . Some authors suggested a role for genetic polymorphisms in the observed inter-individual variability [22] .
Transcranial current stimulation
Transcranial current stimulation refers to the application of an electrical current through a pair of surface electrodes placed on the scalp. tCS does not induce massive synchronized discharge of action potentials as with TMS techniques (e.g. it does not induce activity in resting neuronal networks), but it modulates spontaneous neuronal activity [23, 24] .
Two main tCS techniques have been developed. In the most commonly used technique, tDCS, a weak direct current delivered through the scalp is able to induce polarity-specific changes of resting membrane potential. That is, cortical excitability is diminished by cathodal stimulation which hyperpolarizes neurons, whilst anodal stimulation causes an increase of excitability by depolarizing neurons [23, 25] . The magnitude of the after-effects of tDCS are proportional to the intensity and duration of the applied current. Differently from rTMS, for which the intensity used for any single subject is based on the individual rest or active motor threshold, for tCS (both direct and alternating) there is no such proxy and the intensity is set at either 1 or 2 mA.
With transcranial alternating current stimulation (tACS), both electrodes have equivalent effects that are dependent on the oscillating current frequency [24] . Accordingly, 1 mA tACS with frequency outside the conventional electroencephalogram range [e.g. with frequencies of 140 Hz and in the low kHz range (1-5 kHz)] increases excitability similarly to anodal tDCS [26, 27] . When tACS is applied with frequency in the electroencephalogram range, it is supposed to entrain or synchronize neuronal networks and to induce changes in ongoing oscillatory brain activity. The efficacy of the stimulation seems also to be dependent on the power of intrinsic oscillations at baseline [28] . When applied over M1, 10 Hz or 15 Hz tACS leads to a pattern of inhibition of cortical excitability [29, 30] , whilst 20 Hz tACS increases cortical excitability [31] .
Transcutaneous electrical nerve stimulation
The concept behind TENS stems from the evidence that manipulations of afferent input can induce lasting changes within the primary sensorimotor cortex [32] [33] [34] . The central effects of TENS are dependent on the frequency of the stimulation, with low frequency (1-4 Hz) increasing and high frequency (>50 Hz) depressing sensorimotor excitability. The suggestion that plastic changes occur centrally is corroborated by the fact that peripheral (M-wave) and spinal (H-wave) excitability remain unchanged after TENS [14] . The exact mechanisms whereby TENS modulates sensorimotor excitability are not clear, with some authors speculating it could induce LTP changes at inhibitory synapses [14] .
Search strategy
The Medline database (via PubMed, a service of the National Library of Medicine's National Center for Biotechnology Information; http://www.ncbi.nlm. nih.gov) was searched for anytime publications using the following terms: term A (neuromodulation OR non-invasive brain stimulation OR repetitive transcranial magnetic stimulation OR theta burst stimulation OR transcranial current stimulation OR electrical stimulation OR rTMS OR tCS OR tDCS OR tACS OR TENS) AND term B (dystonia). All types of original articles, including case reports, were included if NIBS protocols were performed for therapeutic purposes or had at least one robust clinical outcome (i.e. pure pathophysiological studies were excluded). Moreover, studies for which details about the stimulation protocol were not fully provided were excluded. Only articles written in English were included. Review articles were checked to include relevant articles not indexed in the electronic database.
Non-invasive brain stimulation in children with dystonia
Only three studies [35] [36] [37] from the same group evaluated the therapeutic potential of NIBS in children with dystonia, of which only one had a doubleblinded, sham-controlled design. All three used tDCS. A summary of the studies evaluating NIBS in children with dystonia is provided in Table 1 . In 2012 Young et al. [35] performed an open-label study with cathodal tDCS in 10 children with dystonia due to different aetiologies (e.g. two patients had idiopathic dystonia, whereas in the remaining eight dystonia was secondary to a variety of causes, Table 1 ) using a single-session cathodal stimulation over the motor cortex contralateral to the most affected side. They failed to demonstrate any improvement on the BarryÀAlbright Dystonia (BAD) Scale but observed a non-significant reduction of the motor overflow during an electromyogram tracking task [35] . Hence, they repeated the experiment on 14 children with dystonia using a double-blinded, sham-controlled design with cathodal tDCS [36] . Similarly to the above, there was no significant clinical change as measured by the BAD scale, but they found a significant reduction in the motor overflow, although the effect size was admittedly small [36] . Finally, Bhanpuri et al. [37] attempted to explore whether repeated tDCS sessions could lead to a cumulative effect with meaningful clinical results in nine patients, again with different aetiologies accounting for their dystonia syndromes. Using a double-blinded, sham-controlled design, they assessed over five sessions whether cathodal or anodal stimulation over the motor cortex contralateral to the most affected side could be beneficial. They failed to demonstrate any clinical and electromyogram changes [37] . However, as observed in prior studies, there was a great intersubject variability and individual analysis suggested that cathodal stimulation over the motor cortex could in fact be beneficial, whereas anodal tDCS even worsened motor performance in some patients. The major pitfall of all three studies is the inclusion of very heterogeneous patients (Table 1) , which hampers drawing definitive conclusions. Although the authors could not identify a clear pattern of response between 'primary' and 'secondary' patients, sample sizes were very small to allow such types of comparison. Therefore, larger double-blinded and sham-controlled studies are required in homogeneous groups of patients. From a practical standpoint, it should be acknowledged that in all three studies a small subset of patients did not tolerate the intensity of the stimulation (initially set between 1 and 2 mA), so that it was reduced below 1 mA and all patients but one could complete the protocol. No major side effects were observed, largely in line with results obtained in other clinical populations of children or adolescents [38] .
Non-invasive brain stimulation in adults with dystonia Focal hand dystonia
Repetitive TMS/TBS Eight studies were examined [39] [40] [41] [42] [43] [44] [45] [46] , of which only one had a double-blinded design. A summary of these studies is provided in Table 2 . There was a high heterogeneity in terms of design (open-label, singleblinded, with or without sham sessions and/or crossover) and of patients included. The majority of studies included patients with writer's cramp (WC) with the rationale of applying inhibitory protocols to the cortical motor areas contralateral to the affected side. Siebner et al. [39] found that a single session of 1 Hz rTMS over M1 reduced writing pressure and this was somewhat mirrored by a normalization of the corticocortical inhibition and a prolongation of the cortical silent period. Similar results were obtained by Murase et al. [41] in a single-blinded, sham-controlled study using 0.2 Hz rTMS over the premotor cortex (PMC) but not M1 or the supplementary motor area (SMA). The therapeutic role of low frequency rTMS over the PMC has been investigated in different studies. A pilot TMS positron emission tomography study on seven FHD patients employed a single session of 1 Hz rTMS for 30 min over the dorsal PMC (dPMC) and evaluated perfusion before and after the magnetic stimulation. Although cerebral blood flow was decreased to a larger extent in the lateral and medial premotor areas, the putamen and the thalamus after inhibitory rTMS of the dPMC in dystonic patients, neither handwriting nor global clinical score improved [40] . Conversely, Borich et al. [42] showed a significant improvement of handwriting performance (lasting up to 10 days after the end of the stimulation period) by inhibiting the PMC with five consecutive 1 Hz rTMS sessions. Importantly, such an improvement was not observed after a single session, suggesting cumulative effects with repeated sessions. In contrast to the above, Kimberley et al. [45] failed to show any clinical improvement by targeting the PMC with five consecutive sessions of 1 Hz rTMS. However, their experimental group was heterogeneous as it included seven patients with WC and five with musicians' dystonia (MD) [45] . The flaw of patient heterogeneity was somewhat investigated in another study from Kimberley et al. [46] which, despite yielding negative results, showed self-rated improvement with large effect sizes (suggesting clinical meaningfulness) in some subjects. The authors therefore advocated the need for identifying baseline predictors to distinguish responders from non-responders [46] . The therapeutic role of the PMC in FHD has been further questioned by Huang et al. [44] who adopted a single-blinded, sham-controlled design with five consecutive sessions of cTBS over the PMC and failed to show any clinical changes, despite a significant increase in cortical inhibition. Finally, the study by Havrankova et al. [43] was the only one adopting a double-blind design with crossover. The authors assessed whether five consecutive sessions of 1 Hz rTMS over S1 could be beneficial in 11 patients with WC and they observed an improvement in both subjective and objective measures of handwriting lasting up to 2 weeks after the stimulation period, although no changes were observed for the BurkeÀFahnÀMarsden Dystonia Scale score [43] .
Transcranial CS Seven studies were included [47] [48] [49] [50] [51] [52] [53] (Table 2 ), all except one of which had a double-blinded design [52] . In two consecutive studies, Buttkus et al. [47, 48] showed that single sessions of both cathodal and anodal tDCS over M1 contralateral to the affected side are not effective in patients with MD. [51] did not show any clinical improvement or cortical excitability changes in 10 patients with WC after anodal tDCS over the ipsilateral cerebellum. Given that high heterogeneity in terms of cortical excitability responses was observed, the authors claimed that inter-subject variability might undermine cerebellar stimulation as a therapeutic strategy for FHD [51] .
Transcutaneous electrical nerve stimulation
Transcutaneous electrical nerve stimulation applied on forearm flexor muscles was used in a randomized, double-blind, placebo-controlled crossover study in 10 WC patients [54] . The frequency of stimulation was 50 Hz and intensity was below the pain threshold and muscular contraction. Electrical stimuli were administered throughout each 20 min session in 2 s trains (100 stimuli/train) separated by 2 s pauses. The authors found that 10 sessions in 2 weeks improved some objective and subjective aspects of writing, although no change was seen in a disability score [54] . The effect lasted for about 6 weeks [54] . In a subsequent study it was demonstrated that handwriting improvement after one TENS session on the forearm flexor muscles was paralleled by a significant reduction of the motor evoked potential (MEP) from the flexor muscles and an increase of the MEP from the extensor muscle in 10 WC patients [55] .
Craniocervical dystonia
Repetitive TMS/TBS Three studies using either rTMS or cTBS were performed in patients with CD [56] [57] [58] , whereas only one study used rTMS in patients with blepharospasm [59] . An overview of these studies is provided in Table 3 . Koch et al. used repeated sessions of cTBS targeting the lateral cerebellum bilaterally in a double-blind, sham-controlled fashion over 2 weeks for a total of 18 CD patients [56] . They found a significant reduction at the end of the protocol for the real cTBS but not for sham stimulation [56] . However, the benefit was not maintained at the 2 and 4 week follow-up [56] . In addition, they demonstrated a reduction of heterotopic paired associative stimulation excessive facilitation following cTBS, suggesting that modulation of CBI can indeed modify some of the pathophysiological substrates of dystonia and lead to a clinical improvement [56] . Pirio Richardson et al. [57] performed a singleblinded, sham-controlled, low frequency rTMS study on a number of cortical areas to find out the best target to use in CD. Although non-significant, larger improvements on the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) were observed following rTMS over M1 and the dPMC [57] . Zittel et al. applied a similar protocol of low frequency rTMS over S1/M1 and demonstrated that shortlatency afferent inhibition could be normalized although this did not reflect any changes in symptom severity [58] .
Finally, Kranz et al. performed a double-blind, sham-controlled study on 12 blepharospasm patients using a single-session low frequency rTMS study [59] . The target was set on the anterior cingulate cortex at the point of maximal MEP for the orbicularis oculi muscle. They found that all clinical outcomes (both patient-and clinician-rated) improved along with a 'normalization' of the blink reflex recovery cycle [59] .
Transcranial CS
Only two case reports [60, 61] have been published thus far, of which one used tDCS and the other a mixed design using both tDCS and tACS. In 2013 Angelakis et al. [60] showed that 15 Hz tACS over C3/C4 (to target the supplemental motor cortex) was superior to cathodal tDCS over C4 and led to a significant improvement of the clinical picture, with the TWSTRS reducing by about 50%. In addition, the pain TWSTRS subscale showed a reduction of almost 75% [60] . It was also shown that the effects persisted for 1 month after the stimulation protocol, suggesting that multiple tACS sessions have cumulative effects [60] . Bradnam et al. [61] instead used repeated sessions of anodal tDCS over the cerebellum, bilaterally, and right M1 (e.g. contralateral to the 'most affected' side). They found a reduction of the TWSTRS of about 40% (the pain TWSTRS subscale decreased by about 55%) as well as of other dystonia-specific quality-of-life scales [61] . The clinical results were mirrored by electrophysiological changes in corticomotor excitability [61] . Importantly, the stimulation protocol was performed starting 1 week after BoNT injections [61] , suggesting that tDCS has the potential to augment BoNT effects.
Discussion
Although only few data are available in dystonia yielding somewhat contradictory results, the work reviewed here could pave the way for future studies on a larger scale. The aims of the current review were to identify potential issues for the use of NIBS for the treatment of dystonia. As a result, four main questions are to be addressed.
Is there any consensus regarding specific NIBS settings to be used?
The results obtained by the studies reviewed here were often negative and this might undermine the theoretical hypothesis behind the use of these techniques as therapeutic tools. It might well be that the intended inhibitory effect of NIBS (by means of low frequency rTMS or anodal tDCS) could not outweigh the excessive cortical excitability observed in dystonia, at least with single stimulation sessions. There is preliminary evidence in fact that cumulative effects can be obtained by repeated stimulation over consecutive days [37, 43, 60] . Hence, the results of single-session studies might have been negative simply because of an insufficient number of stimulation sessions [62] . However, it should also be noted that there is no consensus about the setting of these techniques and an incomplete knowledge of the physiological effects of NIBS. As to rTMS, the after-effects are dependent on the frequencies, phases (monophasic/biphasic) [63] , intensity (sub-threshold or supra-threshold) and on the total number of pulses [64] . Also, the stimulation might be more (or less) focused on the brain target according to the specific type of coil that is used and this might influence the final outcome [59, 65] . Hence, studies comparing different stimulation settings might be useful as well as work aimed to compare different techniques (i.e. rTMS versus tCS). Finally and quite obviously, accurate positioning of the coil/electrodes on the brain target is critical [43] and different studies adopted different ways for the same target. A consensus in this regard would also enhance comparability across different studies.
Is there clarity about the target to be stimulated?
After the initial work by Siebner et al. [39] showing an improvement in FHD after inhibition of M1, Murase et al. [41] provided evidence that the PMC could be a better target and four subsequent studies used the PMC contralateral to the affected side as the stimulation target. Subsequent work yielded contradictory results with four studies failing to show significant benefits in objective measures, even though self-rated improvements were reported in some of these studies [40] [41] [42] [43] [44] [45] [46] . Interestingly, Borich et al. [42] reported an improvement of handwriting performance, but this was only observed after five stimulation sessions. This might imply that the PMC could in fact be a promising target but repeated sessions of stimulation would be required for clinically meaningful effects, as proposed above. Finally, S1 has been proved to be an efficacious alternative target with improvement observed in both objective and subjective measures (again after five sessions of stimulation) [43] . With regard to tDCS, all studies [47] [48] [49] 51, 53] but two [50, 52] failed to show any significant changes on stimulating either M1 or the cerebellum and regardless of the type of stimulation (e.g. cathodal or anodal). Interestingly, the two studies showing a potential benefit of tDCS applied a bi-hemispheric stimulation over the primary sensorimotor cortices with the cathode over the affected hemisphere and in both studies the stimulation was delivered during the execution of motor retraining [50, 52] . It is not entirely clear whether it is the type of montage with bi-hemispheric stimulation or the combination of motor retraining and tDCS that is required to produce the improvement. The few studies performed in CD also yielded contradictory results. The study by Pirio Richardson et al. [57] , similar to that of Murase et al. in FHD [41] , is the only one comparing different stimulation targets in a population of CD. They found that the largest improvement was observed for stimulation of the PMC and M1 [57] . Preliminary positive results (with small size effects) have been demonstrated after cTBS of the cerebellum [56] . As far as tCS is concerned, the two case reports published so far [60, 61] have shown promising results and it has been claimed that tACS could be superior to tDCS, but there are no studies indicating which should be the best target to stimulate.
Although the PMC has been proved to be one of the most promising targets for both FHD and CD, it is unclear why this should be the case. The PMC is a complex structure that has multiple connections with the SMA, the sensorimotor cortex, the anterior cingulate and the basal ganglia, and Tyvaert et al. have demonstrated that sensorimotor integration (one of the main pathophysiological abnormalities in dystonia) could be ameliorated by low frequency rTMS of the PMC [65] . The reasons why stimulating other nodes of the sensorimotor network has not always produced similar results remain to be determined and further physiological studies are warranted to fully understand the 'network effect' of NIBS [13] . Interestingly, there is preliminary evidence that peripheral electrical stimulation would modulate sensorimotor integration and lead to an improvement of dystonia [54, 55] . Modulating sensory afferents by means of a protocol that employs the physiological sensory pathway might prove an approach with higher topographic selectivity, as the stimulation can in fact be delivered on the affected body part.
Is NIBS suitable only for some dystonia populations?
As far as children with dystonia are concerned, despite overall negative results there are some indications that cathodal tDCS over primary sensorimotor cortices can be beneficial to some extent in reducing motor overflow [35] [36] [37] . However, it should be noted that (i) there is a paucity of studies in children with a total population of 33 subjects studied thus far and (ii) there was an impressive heterogeneity in terms of aetiology. All three studies performed in children [35] [36] [37] in fact enrolled subjects with non-progressive cerebral palsy, secondary (progressive) dystonia and genetic forms such as DYT1, rendering the results hardly interpretable. Moreover, it should be noted that in these studies some children did not tolerate the stimulation at full intensity and so it was reduced and this, as mentioned above, might also have affected the results. This is a potential issue that needs to be considered when evaluating NIBS in children. As for now, there is no robust evidence to consider NIBS for dystonia in children.
As to adults with dystonia, the majority of studies were focused on patients with FHD [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] . This is due to the fact that patients with FHD usually respond less to BoNT injections than those with other types of focal dystonia, highlighting the need for novel therapeutic strategies. Moreover, FHD represents an interesting model to explore NIBS given that symptoms are generally confined to one body side. Despite this, there is no clear rationale to argue that only specific dystonia populations would benefit from NIBS, given that the main pathophysiological mechanisms underlying the manifestation of dystonia are shared across different sub-groups [3, 4] . However, opposite results have sometimes been demonstrated for different forms of dystonia. For example, low frequency rTMS over S1 has been shown to enhance short-latency afferent inhibition in CD [58] and to reduce it in WC [66] . Hence, larger studies with homogeneous populations are required to estimate the magnitude of benefit in each of these dystonia groups.
Are available clinical scales sensitive enough to detect minimal changes?
The final question is whether available clinical scales are in fact sensitive enough to detect minimal significant changes. Quite obviously, different scales were adopted across different studies and this hampers comparisons amongst them. One strategy to overcome such a hurdle might be considering as primary outcome in pragmatic randomized clinical trials patients willing to continue the treatment whilst waiting for a more sensitive clinical scale to be developed [67] . On the other hand, clinical assessments should be paralleled by neurophysiological evaluations in order to fully understand the neural circuits that NIBS modulates and possibly identify reliable biomarkers that correlate with dystonic symptom severity.
Conclusions
In summary, there remain many pitfalls regarding NIBS techniques as therapeutic tools for dystonia and at the current time none can be recommended.
Moreover, there is a lack of studies assessing whether NIBS can augment the effectiveness of rehabilitation or pharmacological treatments [68] . It is interesting to note that some authors suggested the potential of NIBS to augment the benefit produced by BoNT injections [61] , so that the NIBS technique could be seen as a complementary rather than alternative treatment. At the current stage, NIBS cannot be recommended for use in dystonia populations. However, further studies, possibly exploring novel techniques [69, 70] , are warranted to see whether NIBS can eventually be implemented in clinical practice.
